MDxHealth S.A.
MXDHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $53,210 | $48,056 | $41,993 | $38,748 |
| % Growth | 10.7% | 14.4% | 8.4% | – |
| Cost of Goods Sold | $18,076 | $18,264 | $16,644 | $13,524 |
| Gross Profit | $35,134 | $29,792 | $25,349 | $25,224 |
| % Margin | 66% | 62% | 60.4% | 65.1% |
| R&D Expenses | $0 | $5,485 | $5,067 | $1,023 |
| G&A Expenses | $12,470 | $11,600 | $11,201 | $40,019 |
| SG&A Expenses | $32,314 | $31,920 | $31,862 | $28,026 |
| Sales & Mktg Exp. | $19,844 | $20,320 | $20,661 | -$11,993 |
| Other Operating Expenses | $6,652 | $3,087 | $2,442 | $7,042 |
| Operating Expenses | $38,966 | $40,492 | $39,371 | $36,091 |
| Operating Income | -$3,832 | -$10,700 | -$14,022 | -$10,867 |
| % Margin | -7.2% | -22.3% | -33.4% | -28% |
| Other Income/Exp. Net | -$11,744 | -$6,948 | -$6,017 | -$9,897 |
| Pre-Tax Income | -$15,576 | -$17,648 | -$20,039 | -$20,764 |
| Tax Expense | -$832 | $382 | $0 | $1 |
| Net Income | -$14,744 | -$18,030 | -$20,039 | -$20,765 |
| % Margin | -27.7% | -37.5% | -47.7% | -53.6% |
| EPS | -0.3 | -0.54 | -0.73 | -0.76 |
| % Growth | 44.4% | 26% | 3.9% | – |
| EPS Diluted | -0.3 | -0.38 | -0.73 | -0.76 |
| Weighted Avg Shares Out | 48,468 | 48,864 | 27,288 | 27,288 |
| Weighted Avg Shares Out Dil | 48,468 | 48,864 | 27,288 | 27,288 |
| Supplemental Information | – | – | – | – |
| Interest Income | $840 | $197 | $1,593 | $564 |
| Interest Expense | $12,584 | $7,145 | $4,663 | $10,461 |
| Depreciation & Amortization | $4,532 | $4,341 | $3,698 | $3,447 |
| EBITDA | $700 | -$6,162 | -$8,953 | -$17,046 |
| % Margin | 1.3% | -12.8% | -21.3% | -44% |